We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.59%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$13.4B
AUM Growth
–
Cap. Flow
+$13.5B
Cap. Flow
% of AUM
100.99%
Top 10 Holdings %
Top 10 Hldgs %
20.99%
Holding
808
New
808
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$519M |
| 2 |
Philip Morris
PM
|
+$473M |
| 3 |
AstraZeneca
AZN
|
+$314M |
| 4 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$272M |
| 5 |
Corning
GLW
|
+$256M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.79% |
| 2 | Technology | 21.35% |
| 3 | Financials | 10.82% |
| 4 | Consumer Staples | 9.85% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
GSK
GSK
$102B
| $511M | 3.81% |
+8,173,369
| New | +$519M |
|
|
2
Philip Morris
PM
$298B
| $441M | 3.29% |
+5,093,020
| New | +$473M |
|
|
3
AstraZeneca
AZN
$261B
| $291M | 2.17% |
+6,161,726
| New | +$314M |
|
|
DTV
4
DELISTED
DIRECTV COM STK (DE)
DTV
| $280M | 2.08% |
+4,536,111
| New | +$272M |
|
|
5
Corning
GLW
$134B
| $251M | 1.87% |
+17,609,013
| New | +$256M |
|
6
Cisco
CSCO
$444B
| $215M | 1.6% |
+8,833,546
| New | +$199M |
|
7
Comcast
CMCSA
$78.3B
| $214M | 1.59% |
+10,216,700
| New | +$211M |
|
8
Eli Lilly
LLY
$1.06T
| $212M | 1.58% |
+4,324,925
| New | +$235M |
|
9
Netflix
NFLX
$287B
| $201M | 1.5% |
+66,637,900
| New | +$198M |
|
10
AbbVie
ABBV
$454B
| $200M | 1.49% |
+4,826,765
| New | +$211M |
|
11
Vodafone
VOD
$35.1B
| $196M | 1.46% |
+6,700,224
| New | +$200M |
|
12
HCA Healthcare
HCA
$83.5B
| $175M | 1.3% |
+4,843,415
| New | +$187M |
|
|
CMCSK
13
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $174M | 1.3% |
+4,397,171
| New | +$174M |
|
14
BP
BP
$113B
| $167M | 1.24% |
+4,887,813
| New | +$170M |
|
15
Pfizer
PFE
$143B
| $167M | 1.24% |
+6,271,174
| New | +$173M |
|
16
Intel
INTC
$504B
| $158M | 1.18% |
+6,539,546
| New | +$154M |
|
17
TSMC
TSM
$2.16T
| $157M | 1.17% |
+8,560,556
| New | +$158M |
|
18
American International
AIG
$41.4B
| $137M | 1.02% |
+3,071,804
| New | +$132M |
|
19
Biogen
BIIB
$29.6B
| $133M | 0.99% |
+617,769
| New | +$132M |
|
20
AutoZone
AZO
$47.7B
| $129M | 0.96% |
+303,951
| New | +$124M |
|
21
Amgen
AMGN
$201B
| $122M | 0.91% |
+1,240,361
| New | +$129M |
|
22
Nokia
NOK
$54.3B
| $122M | 0.91% |
+32,534,691
| New | +$115M |
|
|
SHPG
23
DELISTED
Shire pic
SHPG
| $120M | 0.89% |
+1,260,565
| New | +$118M |
|
24
Sanofi
SNY
$104B
| $119M | 0.89% |
+2,315,598
| New | +$123M |
|
25
Valero Energy
VLO
$90.6B
| $115M | 0.86% |
+3,299,028
| New | +$126M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Arrowstreet Capital, which disclosed 808 positions worth $13.4B. Its ten largest holdings account for 21% of the portfolio.
Its largest position is GSK: 8,173,369 shares worth $511M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Technology and Financials.
- Arrowstreet Capital's largest Q2 2013 buy was GSK: 8,173,369 shares worth $511M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $13.4B portfolio in Q2 2013.
- Arrowstreet Capital disclosed 808 positions in Q2 2013, its first 13F filing on record.
Based on Arrowstreet Capital's 13F filing for Q2 2013, filed 9 Aug 2013.